NCT06865274View on ClinicalTrials.gov

Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Neuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis
Interventions
PROCEDURE

Blood draw for the laboratory assessment

Blood draw of approximately 5 ml of peripheral venous blood (collected in EDTA) will be collected for DNA extraction and genetic analysis limited to the research of FCG3A polymorphisms

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER